Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to international push for MDMA treatment
It’s been a troublesome week for the psychedelics pioneer Rick Doblin. First, the Meals and Drug Management declined to approve the MDMA-assisted treatment for post-traumatic tension dysfunction advanced by means of Lykos